Overview
DMS
?
Venkata Mohan Prasad Gude
See more contacts
Medical and Diagnostic Laboratories
,
Ambulatory Health Care Services
,
Health Care and Social Assistance
,
Medical laboratories
,
Pathological laboratory
Child Care Services
,
Community Food and Housing, and Emergency and Other Relief Services
,
Continuing Care Retirement Communities and Assisted Living Facilities for the Elderly
,
General Medical and Surgical Hospitals
,
Home Health Care Services
,
Individual and Family Services
,
Nursing Care Facilities (Skilled Nursing Facilities)
,
Offices of Dentists
View more , Offices of Other Health Practitioners , Offices of Physicians , Other Ambulatory Health Care Services , Other Residential Care Facilities , Outpatient Care Centers , Psychiatric and Substance Abuse Hospitals , Residential Intellectual and Developmental Disability, Mental Health, and Substance Abuse Facilities , Specialty (except Psychiatric and Substance Abuse) Hospitals Vocational Rehabilitation Services
View fewer
View more , Offices of Other Health Practitioners , Offices of Physicians , Other Ambulatory Health Care Services , Other Residential Care Facilities , Outpatient Care Centers , Psychiatric and Substance Abuse Hospitals , Residential Intellectual and Developmental Disability, Mental Health, and Substance Abuse Facilities , Specialty (except Psychiatric and Substance Abuse) Hospitals Vocational Rehabilitation Services
View fewer
?
?
Modelled
?
Modelled
$94,019
Actual
14.85%
$120
MAR
?
?
Bombay:526504
Contacts
Get in Touch with 5 Principals*
-
Venkata Mohan Prasad GudeChief Executive Officer
-
Contact 2?
-
Contact 3?
-
Contact 4?
Dynamic search and list-building capabilities
Real-time trigger alerts
Comprehensive company profiles
Valuable research and technology reports
Financial Statements
Dun & Bradstreet collects private company financials for more than 23 million companies worldwide. Find out more.
Financial data as of March 31, 2024 (12 month period) in USD
Annual Revenue 2025
$94,019
USD
Actual
1 USD = 82.8976 INR
All financial statement data is in millions except per share data | Source: Morningstar
| Cash Flow (mil) | 2025 | 2024 | 2023 |
|---|---|---|---|
| Net Operating Cash | -$0 | -$0 | -$0 |
| Net Investing Cash | $ | $ | $ |
| Net Financing Cash | $0 | $0 | $0 |
| Net Change in Cash | $0 | $0 | $ |
| Cash at Beginning of Period | $0 | $0 | $0 |
| Cash at End of Period | $0 | $0 | $0 |
| Capital Expenditure | $ | $ | $ |
| Assets (mil) | 2025 | 2024 | 2023 |
|---|---|---|---|
| Current Assets | |||
| Cash and Cash Equivalents | $0 | $0 | $0 |
| Accounts Receivable | $ | $ | $ |
| Inventories | $0 | $0 | $0 |
| Other Current Assets | $0 | $0 | $0 |
| Asset Summary | |||
| Total Current Assets | $0 | $0 | $0 |
| Tangible Fixed Assets | $0 | $0 | $0 |
| Intangible Assets | $0 | $0 | $0 |
| Total Assets | $121 | $121 | $122 |
| Liabilities (mil) | 2025 | 2024 | 2023 |
|---|---|---|---|
| Current Liabilities | |||
| Accounts Payable | $ | $ | $ |
| Short-Term Debt | $ | $ | $ |
| Other Current Liabilities | $0 | $0 | $0 |
| Liability Summary | |||
| Total Current Liabilities | $0 | $0 | $0 |
| Long-Term Debt | $0 | $0 | $0 |
| Other Long-Term Liabilities | $ | $0 | $ |
| Total Liabilities | $0 | $0 | $0 |
| Stakeholder's Equity (mil) | 2025 | 2024 | 2023 |
|---|---|---|---|
| Equity | |||
| Common Stock | $2 | $2 | $2 |
| Retained Earnings | $ | -$1 | -$1 |
| Equity Summary | |||
| Total Equity | $1 | $1 | $1 |
| Shares Outstanding | 15,099,952 | 15,099,952 | 15,099,952 |